BIOMAT Database Logo BIOMAT Database Logo

Drug discovery from natural products. 2006

Vincent P Gullo, and James McAlpine, and Kin S Lam, and Dwight Baker, and Frank Petersen
Cetek Corporation, 260 Cedar Hill Street, Marlborough, MA 01752, USA. v.gullo@cetek.com

Natural product compounds are the source of numerous therapeutic agents. Recent progress to discover drugs from natural product sources has resulted in compounds that are being developed to treat cancer, resistant bacteria and viruses and immunosuppressive disorders. Many of these compounds were discovered by applying recent advances in understanding the genetics of secondary metabolism in actinomycetes, exploring the marine environment and applying new screening technologies. In many instances, the discovery of a novel natural product serves as a tool to better understand targets and pathways in the disease process. This review describes recent progress in drug discovery from natural sources including several examples of compounds that inhibit novel drug targets.

UI MeSH Term Description Entries
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural

Related Publications

Vincent P Gullo, and James McAlpine, and Kin S Lam, and Dwight Baker, and Frank Petersen
Drug discovery from natural products.
August 2009, Nature reviews. Drug discovery,
Vincent P Gullo, and James McAlpine, and Kin S Lam, and Dwight Baker, and Frank Petersen
Combretastatins: from natural products to drug discovery.
December 2003, Natural product reports,
Vincent P Gullo, and James McAlpine, and Kin S Lam, and Dwight Baker, and Frank Petersen
New drug discovery from natural products. Foreword.
March 2010, Indian journal of experimental biology,
Vincent P Gullo, and James McAlpine, and Kin S Lam, and Dwight Baker, and Frank Petersen
New drug discovery from natural products. Preface.
March 2010, Indian journal of experimental biology,
Vincent P Gullo, and James McAlpine, and Kin S Lam, and Dwight Baker, and Frank Petersen
Natural products in drug discovery.
January 2000, Ernst Schering Research Foundation workshop,
Vincent P Gullo, and James McAlpine, and Kin S Lam, and Dwight Baker, and Frank Petersen
Natural products in drug discovery.
October 2008, Drug discovery today,
Vincent P Gullo, and James McAlpine, and Kin S Lam, and Dwight Baker, and Frank Petersen
Natural products and drug discovery.
November 2022, National science review,
Vincent P Gullo, and James McAlpine, and Kin S Lam, and Dwight Baker, and Frank Petersen
Bioactive natural products from marine cyanobacteria for drug discovery.
April 2007, Phytochemistry,
Vincent P Gullo, and James McAlpine, and Kin S Lam, and Dwight Baker, and Frank Petersen
Repositioning Natural Products in Drug Discovery.
March 2020, Molecules (Basel, Switzerland),
Vincent P Gullo, and James McAlpine, and Kin S Lam, and Dwight Baker, and Frank Petersen
Natural products and antifungal drug discovery.
January 2005, Methods in molecular medicine,
Copied contents to your clipboard!